Vitamin D deficiency associates with γ-tocopherol and quadriceps weakness but not inflammatory cytokines in subjects with knee osteoarthritis

Redox Biology

Volumn 2, Issue 1, 2014, Pages 466-474

  Barker, Tyler ^a   Henriksen, Vanessa T ^a,b   Rogers, Victoria E ^a   Aguirre, Dale ^a   Trawick, Roy H ^a,b   Lynn Rasmussen, G ^a,b   Momberger, Nathan G ^a,b  

^a Orthopedic Specialty Hospital   (United States)

^b The Orthopedic Specialty Clinic   (United States)

Author keywords

Cytokines; Muscle strength; Vitamin D; Vitamin E

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA CAROTENE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BETA TOCOPHEROL; CYTOKINE; GAMMA TOCOPHEROL; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; CALCIUM; PARATHYROID HORMONE; RHEUMATOID FACTOR; TNF PROTEIN, HUMAN; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DECELERATION; DISEASE ASSOCIATION; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUADRICEPS FEMORIS MUSCLE; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE BLOOD LEVEL; MUSCLE CONTRACTION; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL CAPACITY; TORQUE; BLOOD; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; FEMALE; GAMMA-TOCOPHEROL; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; OSTEOARTHRITIS, KNEE; QUADRICEPS MUSCLE; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84894695791     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.01.024     Document Type: Article

References (82)

1. McAlindon T.E., Felson D.T., Zhang Y., Hannan M.T., Aliabadi P., Weissman B., Rush D., Wilson P.W., Jacques P. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study. Ann. Intern. Med. 1996, 125:353-359.
2. Heidari B., Heidari P., Hajian-Tilaki K. Association between serum vitamin D deficiency and knee osteoarthritis. Int. Orthop. 2010, 35:1627-1631.
3. Muraki S., Dennison E., Jameson K., Boucher B.J., Akune T., Yoshimura N., Judge A., Arden N.K., Javaid K., Cooper C. Association of vitamin D status with knee pain and radiographic knee osteoarthritis. Osteoarthr. Cartil. 2011, 19:1301-1306.
4. Ding C., Cicuttini F., Parameswaran V., Burgess J., Quinn S., Jones G. Serum levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults: the Tasmanian older adult cohort study. Arthritis Rheum. 2009, 60:1381-1389.
5. Al-Jarallah K.F., Shehab D., Al-Awadhi A., Nahar I., Haider M.Z., Moussa M.A. Are 25(OH)D levels related to the severity of knee osteoarthritis and function?. Med. Princ. Pract. 2011, 21:74-78.
6. Felson D.T., Niu J., Clancy M., Aliabadi P., Sack B., Guermazi A., Hunter D.J., Amin S., Rogers G., Booth S.L. Low levels of vitamin D and worsening of knee osteoarthritis: results of two longitudinal studies. Arthritis Rheum. 2007, 56:129-136.
7. Konstari S., Paananen M., Heliovaara M., Knekt P., Marniemi J., Impivaara O., Arokoski J., Karppinen J. Association of 25-hydroxyvitamin D with the incidence of knee and hip osteoarthritis: a 22-year follow-up study. Scand. J Rheumatol. 2011, 41:124-131.
8. Hurley M.V., Scott D.L. Improvements in quadriceps sensorimotor function and disability of patients with knee osteoarthritis following a clinically practicable exercise regime. Br. J. Rheumatol. 1998, 37:1181-1187.
9. Santos M.L., Gomes W.F., Pereira D.S., Oliveira D.M., Dias J.M., Ferrioli E., Pereira L.S. Muscle strength, muscle balance, physical function and plasma interleukin-6 (IL-6) levels in elderly women with knee osteoarthritis (OA). Arch. Gerontol. Geriatr. 2011, 52:322-326.
10. Slemenda C., Brandt K.D., Heilman D.K., Mazzuca S., Braunstein E.M., Katz B.P., Wolinsky F.D. Quadriceps weakness and osteoarthritis of the knee. Ann. Intern. Med. 1997, 127:97-104.
11. Fisher N.M., Pendergast D.R., Gresham G.E., Calkins E. Muscle rehabilitation: its effect on muscular and functional performance of patients with knee osteoarthritis. Arch. Phys. Med. Rehabil. 1991, 72:367-374.
12. Houston D.K., Tooze J.A., Neiberg R.H., Hausman D.B., Johnson M.A., Cauley J.A., Bauer D.C., Cawthon P.M., Shea M.K., Schwartz G.G., Williamson J.D., Tylavsky F.A., Visser M., Simonsick E.M., Harris T.B., Kritchevsky S.B. 25-hydroxyvitamin D status and change in physical performance and strength in older adults: the health, aging, and body composition study. Am. J. Epidemiol. 2012, 176:1025-1034.
13. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., Hu F.B., Zhang Y., Karlson E.W., Dawson-Hughes B. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged>or=60y. Am. J. Clin. Nutr. 2004, 80:752-758.
14. Mastaglia S.R., Seijo M., Muzio D., Somoza J., Nunez M., Oliveri B. Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years. J. Nutr. Health Aging 2011, 15:349-354.
15. Wicherts I.S., van Schoor N.M., Boeke A.J., Visser M., Deeg D.J., Smit J., Knol D.L., Lips P. Vitamin D status predicts physical performance and its decline in older persons. J. Clin. Endocrinol. Metab. 2007, 92:2058-2065.
16. Visser M., Deeg D.J., Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J. Clin. Endocrinol. Metab. 2003, 88:5766-5772.
17. Dhesi J.K., Bearne L.M., Moniz C., Hurley M.V., Jackson S.H., Swift C.G., Allain T.J. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J. Bone Miner. Res. 2002, 17:891-897.
18. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol. Asp. Med. 2008, 29:407-414.
19. Boland R.L. VDR activation of intracellular signaling pathways in skeletal muscle. Mol. Cell Endocrinol. 2011, 347:11-16.
20. Bischoff-Ferrari H.A., Dawson-Hughes B., Stocklin E., Sidelnikov E., Willett W.C., Orav E.J., Stahelin H.B., Wolfram S., Jetter A., Schwager J., Henschkowski J., von E.A., Egli A. Oral supplementation with 25(OH)D(3) versus vitamin D(3): effects on 25(OH)D levels, lower extremity function, blood pressure and markers of innate immunity. J. Bone Miner. Res. 2011.
21. Sato Y., Iwamoto J., Kanoko T., Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc. Dis. 2005, 20:187-192.
22. Annweiler C., Schott-Petelaz A.M., Berrut G., Kressig R.W., Bridenbaugh S., Herrmann F.R., Beauchet O. Vitamin D deficiency-related quadriceps weakness: results of the epidemiologie De l'Osteoporose cohort. J. Am. Geriatr. Soc. 2009, 57:368-369.
23. Kenny A.M., Biskup B., Robbins B., Marcella G., Burleson J.A. Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J. Am. Geriatr. Soc. 2003, 51:1762-1767.
24. McAlindon T., LaValley M., Schneider E., Nuite M., Lee J.Y., Price L.L., Lo G., Dawson-Hughes B. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. J. Am. Med. Assoc. 2013, 309:155-162.
25. Sowers M., Jannausch M., Stein E., Jamadar D., Hochberg M., Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthr. Cartil. 2002, 10:595-601.
26. Spector T.D., Hart D.J., Nandra D., Doyle D.V., Mackillop N., Gallimore J.R., Pepys M.B. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997, 40:723-727.
27. Pelletier J.P., Raynauld J.P., Caron J., Mineau F., Abram F., Dorais M., Haraoui B., Choquette D., Martel-Pelletier J. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann. Rheum. Dis. 2010, 69:2095-2101.
28. Stannus O., Jones G., Cicuttini F., Parameswaran V., Quinn S., Burgess J., Ding C. Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthr. Cartil. 2010, 18:1441-1447.
29. Livshits G., Zhai G., Hart D.J., Kato B.S., Wang H., Williams F.M., Spector T.D. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford study. Arthritis Rheum. 2009, 60:2037-2045.
30. Smith M.D., Triantafillou S., Parker A., Youssef P.P., Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J. Rheumatol. 1997, 24:365-371.
31. Pearle A.D., Scanzello C.R., George S., Mandl L.A., DiCarlo E.F., Peterson M., Sculco T.P., Crow M.K. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthr. Cartil. 2007, 15:516-523.
32. Devaraj S., Yun J.M., Duncan-Staley C.R., Jialal I. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am. J. Clin. Pathol. 2011, 135:429-433.
33. Khoo A.L., Chai L.Y., Koenen H.J., Sweep F.C., Joosten I., Netea M.G., van der Ven A.J. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin. Exp. Immunol. 2011, 164:72-79.
34. Barker T. Vitamin D and inflammation. Nutrition & Physical Activity in Inflammatory Diseases 2013, 75-86. CABI, Boston. M.L. Garg, L.G. Wood (Eds.).
35. Dusso A.S., Brown A.J., Slatopolsky E., Vitamin D. Am. J. Physiol. Ren. Physiol. 2005, 289:F8-28.
36. Barker T., Martins T.B., Hill H.R., Kjeldsberg C.R., Dixon B.M., Schneider E.D., Henriksen V.T., Weaver L.K. Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults. Eur. J. Appl. Physiol. 2013, 113:1523-1534.
37. Bellia A., Garcovich C., D'Adamo M., Lombardo M., Tesauro M., Donadel G., Gentileschi P., Lauro D., Federici M., Lauro R., Sbraccia P. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern. Emerg. Med. 2013, 8:33-40.
38. Milovanovic M., Pesic G., Nikolic V., Jevtovic-Stoimenov T., Vasic K., Jovic Z., Deljanin-Ilic M., Pesic S. Vitamin D deficiency is associated with increased IL-17 and TNFalpha levels in patients with chronic heart failure. Arq. Bras. Cardiol. 2012, 98:259-265.
39. Shab-Bidar S., Neyestani T.R., Djazayery A., Eshraghian M.R., Houshiarrad A., Kalayi A., Shariatzadeh N., Khalaji N., Gharavi A. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab. Res. Rev. 2012, 28:424-430.
40. Mah E., Pei R., Guo Y., Ballard K.D., Barker T., Rogers V.E., Parker B.A., Taylor A.W., Traber M.G., Volek J.S., Bruno R.S. Gamma-tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation. Free Radic. Biol. Med. 2013, 65C:1291-1299.
41. Devaraj S., Leonard S., Traber M.G., Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic. Biol. Med. 2008, 44:1203-1208.
42. Devaraj S., Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of {alpha}-tocopherol supplementation. Circulation 2000, 102:191-196.
43. England A., Valdes A.M., Slater-Jefferies J.L., Gill R., Howell W.M., Calder P.C., Grimble R.F. Variants in the genes encoding TNF-alpha, IL-10, and GSTP1 influence the effect of alpha-tocopherol on inflammatory cell responses in healthy men. Am. J. Clin. Nutr. 2012, 95:1461-1467.
44. Wiser J., Alexis N.E., Jiang Q., Wu W., Robinette C., Roubey R., Peden D.B. In vivo gamma-tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects. Free Radic. Biol. Med. 2008, 45:40-49.
45. Hartel C., Strunk T., Bucsky P., Schultz C. Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine 2004, 27:101-106.
46. Prabhala R.H., Braune L.M., Garewal H.S., Watson R.R. Influence of beta-carotene on immune functions. Ann. N. Y. Acad. Sci. 1993, 691:262-263.
47. Hughes D.A., Wright A.J., Finglas P.M., Peerless A.C., Bailey A.L., Astley S.B., Pinder A.C., Southon S. The effect of beta-carotene supplementation on the immune function of blood monocytes from healthy male nonsmokers. J. Lab. Clin. Med. 1997, 129:309-317.
48. Hughes D.A., Finglas P.M., Wright A.J., Peerless A.C., Bailey A.L., Astley S.B., Southon S. Dietary beta-carotene supplementation modulates the production of tumour necrosis factor-alpha by human monocytes. Biochem. Soc. Trans. 1996, 24:387S.
49. Duncan A., Talwar D., McMillan D.C., Stefanowicz F., O'Reilly D.S. Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am. J. Clin. Nutr. 2012, 95:64-71.
50. Erlinger T.P., Guallar E., Miller E.R., Stolzenberg-Solomon R., Appel L.J. Relationship between systemic markers of inflammation and serum beta-carotene levels. Arch. Intern. Med. 2001, 161:1903-1908.
51. D'Adamo C.R., Miller R.R., Shardell M.D., Orwig D.L., Hochberg M.C., Ferrucci L., Semba R.D., Yu-Yahiro J.A., Magaziner J., Hicks G.E. Higher serum concentrations of dietary antioxidants are associated with lower levels of inflammatory biomarkers during the year after hip fracture. Clin. Nutr. 2012, 31:659-665.
52. Barker T., Martins T.B., Kjeldsberg C.R., Trawick R.H., Hill H.R. Circulating interferon-gamma correlates with 1,25(OH)D and the 1,25(OH)D-to-25(OH)D ratio. Cytokine 2012, 60:23-26.
53. Barker T., Leonard S.W., Trawick R.H., Martins T.B., Kjeldsberg C.R., Hill H.R., Traber M.G. Modulation of inflammation by vitamin E and C supplementation prior to anterior cruciate ligament surgery. Free. Radic. Biol. Med. 2009, 46:599-606.
54. Henriksen V.T., Rogers V.E., Rasmussen G.L., Trawick R.H., Momberger N.G., Aguirre D., Barker T. Pro-inflammatory cytokines mediate the decrease in serum 25(OH)D concentrations after total knee arthroplasty?. Med. Hypotheses 2014, 82:134-137.
55. Reid D., Toole B.J., Knox S., Talwar D., Harten J., J.O., Blackwell S., Kinsella J., McMillan D.C., Wallace A.M. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am. J. Clin. Nutr. 2011, 93:1006-1011.
56. Louw J.A., Werbeck A., Louw M.E., Kotze T.J., Cooper R., Labadarios D. Blood vitamin concentrations during the acute-phase response. Crit. Care Med. 1992, 20:934-941.
57. Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L.W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J. Rheumatol. 1988, 15:1833-1840.
58. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 1957, 16:494-502.
59. Barker K., Lamb S.E., Toye F., Jackson S., Barrington S. Association between radiographic joint space narrowing, function, pain and muscle power in severe osteoarthritis of the knee. Clin. Rehabil. 2004, 18:793-800.
60. Segal N.A., Torner J.C., Felson D.T., Niu J., Sharma L., Lewis C.E., Nevitt M. Knee extensor strength does not protect against incident knee symptoms at 30 months in the multicenter knee osteoarthritis (MOST) cohort. PM R 2009, 1:459-465.
61. Hall M.C., Mockett S.P., Doherty M. Relative impact of radiographic osteoarthritis and pain on quadriceps strength, proprioception, static postural sway and lower limb function. Ann. Rheum. Dis. 2006, 65:865-870.
62. Creamer P., Lethbridge-Cejku M., Hochberg M.C. Factors associated with functional impairment in symptomatic knee osteoarthritis. Rheumatology (Oxford) 2000, 39:490-496.
63. McAlindon T.E., Cooper C., Kirwan J.R., Dieppe P.A. Determinants of disability in osteoarthritis of the knee. Ann. Rheum. Dis. 1993, 52:258-262.
64. Steultjens M.P., Dekker J., van Baar M.E., Oostendorp R.A., Bijlsma J.W. Muscle strength, pain and disability in patients with osteoarthritis. Clin. Rehabil. 2001, 15:331-341.
65. Bruyere O., Honore A., Rovati L.C., Giacovelli G., Henrotin Y.E., Seidel L., Reginster J.Y. Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Scand. J. Rheumatol. 2002, 31:13-16.
66. Radin E.L., Rose R.M. Role of subchondral bone in the initiation and progression of cartilage damage. Clin. Orthop. Relat. Res. 1986, 34-40.
67. Penninx B.W., Abbas H., Ambrosius W., Nicklas B.J., Davis C., Messier S.P., Pahor M. Inflammatory markers and physical function among older adults with knee osteoarthritis. J. Rheumatol. 2004, 31:2027-2031.
68. Visser M., Pahor M., Taaffe D.R., Goodpaster B.H., Simonsick E.M., Newman A.B., Nevitt M., Harris T.B. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci. 2002, 57:M326-M332.
69. Schaap L.A., Pluijm S.M., Deeg D.J., Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am. J. Med. 2006, 119. (e9-e17).
70. Cesari M., Penninx B.W., Pahor M., Lauretani F., Corsi A.M., Rhys W.G., Guralnik J.M., Ferrucci L. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:242-248.
71. Stannus O.P., Jones G., Blizzard L., Cicuttini F.M., Ding C. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann. Rheum. Dis. 2013, 72:535-540.
72. McLaughlin P.J., Weihrauch J.L. Vitamin E content of foods. J. Am. Diet Assoc. 1979, 75:647-665.
73. Lehmann J., Martin H.L., Lashley E.L., Marshall M.W., Judd J.T. Vitamin E in foods from high and low linoleic acid diets. J. Am. Diet Assoc. 1986, 86:1208-1216.
74. Barker T. Vitamin E and inflammation. Nutrition & Physical Activity in Inflammatory Diseases 2013, 87-98. CABI, Boston. M.L. Garg, L.G. Wood (Eds.).
75. Jiang Q., Gamma-tocopherol Ames B.N. but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. J. Federation Am. Soc. Exp. Biol. 2003, 17:816-822.
76. Jiang Q., Elson-Schwab I., Courtemanche C., Ames B.N. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11494-11499.
77. Jiang Z., Yin X., Jiang Q. Natural forms of vitamin E and 13'-carboxychromanol, a long-chain vitamin E metabolite, inhibit leukotriene generation from stimulated neutrophils by blocking calcium influx and suppressing 5-lipoxygenase activity, respectively. J. Immunol. 2011, 186:1173-1179.
78. Joosten L.A., Helsen M.M., van de Loo F.A., van den Berg W.B. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum. 1996, 39:797-809.
79. Ruggiero C., Cherubini A., Guralnik J., Semba R.D., Maggio M., Ling S.M., Lauretani F., Bandinelli S., Senin U., Ferrucci L. The interplay between uric acid and antioxidants in relation to physical function in older persons. J. Am. Geriatr. Soc. 2007, 55:1206-1215.
80. Dalbeth N., Horne A., Gamble G.D., Ames R., Mason B., McQueen F.M., Bolland M.J., Grey A., Reid I.R. The effect of calcium supplementation on serum urate: analysis of a randomized controlled trial. Rheumatology (Oxford) 2009, 48:195-197.
81. Hui J.Y., Choi J.W., Mount D.B., Zhu Y., Zhang Y., Choi H.K. The independent association between parathyroid hormone levels and hyperuricemia: a national population study. Arthritis Res. Ther. 2012, 14:R56.
82. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., Meunier P.J. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 1997, 7:439-443.